Cargando…
Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination
Despite current therapeutic strategies for immunomodulation and relief of symptoms in multiple sclerosis (MS), remyelination falls short due to dynamic neuropathologic deterioration and relapses, leading to accrual of disability and associated patient dissatisfaction. The potential of cannabinoids i...
Autores principales: | Longoria, Victor, Parcel, Hannah, Toma, Bameelia, Minhas, Annu, Zeine, Rana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945692/ https://www.ncbi.nlm.nih.gov/pubmed/35327341 http://dx.doi.org/10.3390/biomedicines10030539 |
Ejemplares similares
-
Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2020) -
Cannabinoids-Promising Antimicrobial Drugs or Intoxicants with Benefits?
por: Klahn, Philipp
Publicado: (2020) -
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
por: Giacoppo, Sabrina, et al.
Publicado: (2014) -
Editorial: Neuropathology of Autoimmune Inflammatory Demyelination Disorders
por: Zeitelhofer, Manuel, et al.
Publicado: (2022) -
Mitochondria as Crucial Players in Demyelinated Axons: Lessons
from Neuropathology and Experimental Demyelination
por: Campbell, Graham R., et al.
Publicado: (2011)